Abeona's $3.1M gene therapy wins FDA nod for rare skin disease on April 30, 2025 Abeona Abeona 's Approved Dermatologic disorders gene therapy Hallopeau-Siemens Disease Infrequent United States Food and Drug Administration ZEVASKYN +
FDA approves Abeonas skin disease cell therapy on April 29, 2025 Abeona Approved gene therapy Hallopeau-Siemens Disease Treating United States Food and Drug Administration Wounds - qualifier ZEVASKYN +